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Within the crowded and complex environment of the cell, a protein experiences
stabilizing excluded-volume effects and destabilizing quinary interactions with other
proteins. Which of these prevail, needs to be determined on a case-by-case basis.
PAPS synthases are dimeric and bifunctional enzymes, providing activated sulfate in
the form of 3′-phosphoadenosine-5′-phosphosulfate (PAPS) for sulfation reactions. The
human PAPS synthases PAPSS1 and PAPSS2 differ significantly in their protein stability
as PAPSS2 is a naturally fragile protein. PAPS synthases bind a series of nucleotide
ligands and some of them markedly stabilize these proteins. PAPS synthases are of
biomedical relevance as destabilizing point mutations give rise to several pathologies.
Genetic defects in PAPSS2 have been linked to bone and cartilage malformations as
well as a steroid sulfation defect. All this makes PAPS synthases ideal to study protein
unfolding, ligand binding, and the stabilizing and destabilizing factors in their cellular
environment. This review provides an overview on current concepts of protein folding and
stability and links this with our current understanding of the different disease mechanisms
of PAPSS2-related pathologies with perspectives for future research and application.
Keywords: sulfation pathways, PAPS synthase, quinary interaction, excluded volume effect, ligand stabilization,
enzyme storage complex
INTRODUCTION
Sulfation pathways are centered around enzymatic conversion of sulfate to the activated sulfate
donor 3′-phosphoadenosine-5′-phosphosulfate (PAPS) and the transfer of the sulfuryl moiety
to biological acceptor molecules (Foster and Mueller, 2018). The enzymes in charge are PAPS
synthases (Mueller and Shafqat, 2013) and PAPS-dependent sulfotransferases (Coughtrie, 2016;
Hirschmann et al., 2017), respectively. Sulfation pathways also include the removal of sulfate
by sulfatases (Mueller et al., 2015) and the deactivation of the sulfation-byproduct 3′-phospho-
adenosine-5′-phosphate (PAP) by dedicated PAP phosphatases (Chan et al., 2016). Sulfation
impacts on many different acceptor molecules, such as carbohydrates, proteins, lipids, xenobiotics,
and steroids as well as other hormones (Mueller et al., 2015). Several proteins from this pathway
have been studied with regard to their stability; some of them giving rise to clinically observed
pathologies (Oostdijk et al., 2015).
An experimental categorization into thermostable and thermolabile sulfotransferases (Reiter
and Weinshilboum, 1982) was an early apprehension of the multiplicity of sulfation pathways
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we know of today. Unfolding was then monitored as loss-
of-activity measurements upon thermal increase. Midpoints of
unfolding of sulfation activity towards dopamine were 39.5◦C,
but 44◦C for a phenol-targeting sulfotransferase (Reiter and
Weinshilboum, 1982). Hence, thermostability was understood
as being folded and active at about physiological temperature.
This system was in use until more and more sulfotransferase
genes were cloned (Dubin et al., 2001). Later, sulfotransferase
proteins were purported to form dimers via an unusually small
protein interface (Petrotchenko et al., 2001; Weitzner et al.,
2009). Dimerization is thought to increase structural stability of
human sulfotransferase SULT1A1, both with regards to thermal
inactivation and chemically induced unfolding (Lu et al., 2009).
Only in 2012, the first biophysical study of sulfate-activating
PAPS synthase enzymes (van den Boom et al., 2012) identified
one of them, human PAPSS2, as a fragile protein specifically
stabilized by ligand binding (van den Boom et al., 2012;
Mueller and Shafqat, 2013). PAPS synthases are bifunctional
enzymes comprising a C-terminal ATP sulfurylase and an N-
terminal APS kinase domain (Mueller and Shafqat, 2013). Their
physiological substrates and products are sulfate, ATP, ADP,
pyrophosphate, PAPS, and the reaction intermediate adenosine-
5′-phosphosulfate (APS) (Strott, 2002). Out of these, ADP
and PAPS had moderately stabilizing effects, but APS shifted
unfolding transitions by more than 16◦C (van den Boom
et al., 2012). The relevance of this finding for intracellular
sulfation pathways is not yet clear as concentrations of the
intermediate APS are expected to change considerably within the
cell (Lansdon et al., 2004).
Various point mutations have been described for the PAPSS2
gene that lead to bone and cartilage malformations (Oostdijk
et al., 2015) as well as a steroid sulfation defect (Noordam et al.,
2009; Oostdijk et al., 2015). A subset of these mutations seems to
destabilize the PAPSS2 protein severely, inducing its intracellular
aggregation and triggering its ubiquitination and degradation via
the proteasome (Oostdijk et al., 2015). Interestingly, PAPSS2 is
involved in transient protein interactions with other sulfation
pathway proteins (Mueller et al., 2018) and these interactions
may stabilize or activate the PAPSS2 protein. This reviewwill look
at sulfation pathways, central to healthy human physiology from
a protein-stability/protein-folding perspective.
PAPS SYNTHASE PROTEINS DISPLAY
SUBSTRATE-SPECIFIC FOLDING
PROPERTIES
Understanding structure, function, and stability of proteins
as the cellular workforce to generate vital biomolecules has
been of great interest ever since (Bryngelson et al., 1995).
Protein folding becomes especially important due to the many
examples of malfunctioning proteins causally linked to severe
diseases, such as Huntington’s (McColgan and Tabrizi, 2018)
and Parkinson’s disease (Poewe et al., 2017). Many proteins
are functional on their own, but intermolecular interactions
such as dimer or multimer formation are common features
of proteins (Marsh and Teichmann, 2015). These quaternary
structures result from highly specific interactions encouraged
by complementary surface properties of the proteins involved.
They may represent the functional form of many proteins
(Dobson et al., 2004), regulate activity (Grum et al., 2010) or
be included in signal pathways (Heldin, 1995) and trafficking
between compartments (Knauer et al., 2005; Schröder et al.,
2012; Eggert et al., 2018). Compared to smooth interactions
such as multimer formation, intermolecular protein interactions
may also have a fuzzy nature. Interactions resulting in
these fuzzy complexes usually involve intrinsically disordered
regions that interact with each other to form for example
signalosomes or phase-separating ribonucleoprotein granules
(Wu and Fuxreiter, 2016; Alberti et al., 2019).
Within the complex environment of the living cell,
transient interactions with other biomolecules may occur
and these have been named quinary interactions (McConkey,
1982) as a continuation of primary, secondary, tertiary and
quaternary structure (Cohen and Pielak, 2017). However,
commonly biomolecules are probed in dilute buffer solutions
or in crystals by techniques such as NMR spectroscopy or
crystallography. Thus, protein functions relying on transient
protein interactions mostly remain unnoticed or are very hard to
study (Matena et al., 2013).
The different structural and interaction levels of proteins
create a multidimensional rugged energy landscape with
several small energetic minima representing different possible
conformations of the polypeptide chain (Bryngelson et al.,
1995). Even though the energy landscape in theory allows many
marginally stable conformations, protein folding and unfolding
of small single-domain proteins can often be described by a
two-state model (Figure 1A). The unfolded protein needs to
cross a transition state comprised of an ensemble of partially
folded structures in order to fold downhill into its native
conformation, by forming intramolecular interactions in a
cooperative manner (Bryngelson et al., 1995; Oliveberg and
Wolynes, 2005). This one-dimensional energy landscape model
allows to precisely determine rates of protein folding as a
folding “speed limit” (Kubelka et al., 2004). The influence of
intermolecular and intramolecular interactions as well as pH or
viscosity on folding and the ruggedness of the landscape are still
investigated extensively (Chung et al., 2015; Chung and Eaton,
2018). However, the simple model needs adjustments when
describing folding of large multi-domain proteins. Multi-domain
proteins may form stable and biologically relevant intermediates
representing distinct energy minima on the protein folding
energy landscape. This applies to proteins with independently
folding domains (Ferreiro et al., 2005) or those requiring specific
interactions with substrates or cofactors (Klein and Schwarz,
2012; van den Boom et al., 2012). The actual positioning on the
reaction coordinate and their stability compared to the unfolded
and folded state may differ according to the number of contacts
already formed in this structure. PAPS synthases with their two
independently folding domains are a good example for multi-
state folder.
The 140 kDa dimeric PAPS synthase proteins unfold
irreversibly thermally and chemically, when studied as
recombinant proteins in vitro (van den Boom et al., 2012).
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FIGURE 1 | A theoretical and an experimental perspective on protein folding.
(A) Schematic representation of the folding free energy landscape for a
multi-state (black) and two-state folder (red). Kinetic constants for folding and
unfolding (kf and ku ) are depicted with arrows highlighting the transitions
between unfolded (U), intermediate (I), and folded (F) states. (B) Thermal CD
unfolding data of PAPS synthase 2 adapted from van den Boom et al. (2012).
Experiments without (red) and with (black) the APS nucleotide at a 100 fold
excess of APS. Transitions observed fit the expected data for a two-state
folder with one transition and a three-state folder with two distinguishable
transitions. Multi-state behavior is only observed upon APS binding.
Their reaction intermediate, the nucleotide adenosine-5′-
phosphosulfate, has two effects on the unfolding thermographs
(Figure 1B). At low APS concentrations, equal to or slightly
higher than the protein, unfolding transitions shift remarkably
by about 5◦C. At higher APS concentrations, even the form of the
unfolding transition changed and a clear unfolding intermediate
is seen (van den Boom et al., 2012). The high-affinity effect can
be explained by forming a stable dead-end enzyme-ADP-APS
complex in the APS kinase domain (Mueller and Shafqat,
2013), further discussed below. The ADP for this complex
most likely is carried over through the purification process as
it is tightly enzyme-bound (Mueller and Shafqat, 2013). The
low-affinity effect is most likely due to stabilization of the ATP
sulfurylase domain (van den Boom et al., 2012). In summary,
this shows that PAPS synthase proteins display complex and
substrate-specific folding properties that could play a important
role in the regulation of sulfation pathways. It will be crucial
to study PAPS synthase stability in a cellular environment with
tightly regulated substrate concentrations and the crowded
environment described below.
PUSH AND PULL—CROWDED CELLS VS.
BUFFER SOLUTIONS
In comparison to dilute solution, the cellular environment is
crowded with up to 300 g/L of biopolymers (Zimmerman
and Trach, 1991; Ellis and Minton, 2003). Biomolecules in
such environments are influenced by a many of specific and
non-specific interactions. Metaphorically speaking, comparing
a biomolecule in dilute solution to the situation in the cell
is like comparing an elegant ballet dancer in an empty
dancing hall with a person in an overcrowded night-club.
Random interactions and collisions are rare in the first case,
but unavoidable in the second. Scientifically speaking, the
consequences of the random interactions and the collisions in
the cellular “night-club” are referred to as excluded-volume
effects (Minton, 1983) and quinary interactions (McConkey,
1982), respectively.
Within the concept of excluded-volume, macromolecules
primarily repel each other. High macromolecule concentrations
increase the occupied volume and decrease the volume accessible
for other macromolecules, hence, reducing the configurational
entropy of less compact conformations. With regards to proteins,
this favors compact protein conformations that normally are the
functional protein folds (Minton andWilf, 1981). Indeed, in vitro
experiments show that an artificially crowded environment
using large polymers such as PEG or Ficoll-70 stabilizes native
conformations (Alfano et al., 2017) and favors protein association
(Batra et al., 2009) and catalytic activity (Dhar et al., 2010; Paudel
et al., 2018). However, a physicochemical force driving proteins
into their most compact conformation will unavoidably also
affect aggregation-prone proteins and increase aggregation rates
in a crowded environment (Hatters et al., 2002; Gao et al., 2015).
The concept of quinary interactions describes the organization
of large biomolecules via weak and transient interactions
(McConkey, 1982). In contrast to repulsive interactions, transient
interactions depend on the chemical composition of the
biomolecule and the crowding agent (Minton, 2013). Since
crowding agents, used to mimic the cellular environment, differ
in their chemical properties, their effects on a target protein
studied in vitro may hence differ as well (Senske et al., 2014;
Feig et al., 2017; Majumdar et al., 2018). While some crowding
agents such as PEG directly interact with a protein, others such
as dextran rather affect the water network and the solvation of
the protein (Senske et al., 2014). This mechanism is comparable
to the thermodynamic stabilization of proteins by osmolytes
(Yancey et al., 1982; Senske et al., 2014, 2016). Recently, the effects
of quinary interactions on protein stability have been correlated
with protein surface properties – the increase in surface charge
is a key factor for the formation of quinary interactions (Gnutt
et al., 2019). These well-studied concepts show that in addition
to the intrinsic stability of the protein fold, weak and repulsive
interactions in a cellular environment need to be considered
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as well for a complete view on protein folding and stability.
Detailed effects of the cellular environment and how intracellular
crowding is mimicked in vitro were discussed here (Politou and
Temussi, 2015; Gnutt and Ebbinghaus, 2016).
Understanding how a protein folds and how it is stabilized,
when surrounded by hundreds of other macromolecules with
a myriad of unspecific interactions is a complex task. Several
approaches have been applied to disentangle the physicochemical
effects exerted on biomolecules inside the cell, ranging from
fluorescent crowding sensors (Boersma et al., 2015; Gnutt et al.,
2015) to case-studies in cell lysates (Martin and Hartl, 1997)
or whole cell simulations (Feig et al., 2017). Within living cells,
similar studies have been performed using an RNA hairpin (Gao
et al., 2016), the glycolytic PGK enzyme (Dhar et al., 2011; Wirth
et al., 2013), superoxide dismutase 1 (Gnutt et al., 2019), cell
volume changes (Wang et al., 2018), and intracellular osmolytes
(Sukenik et al., 2018). Very recently, the repertoire of in-cell
protein analysis has been expanded to live zebrafish (Feng et al.,
2019). It appears that the net-effect on thermal stability of a
specific protein or sensor inside cells cannot be generalized and
highly depends on the surface exposed. This complexity makes it
inevitable to use in-cell techniques to study proteins within their
native environment complemented with in vitro experiments.
An orthogonal method to study in-cell protein stability
represents mass-spectrometry of isotopically labeled cells. A
pioneering study in this regard reported thermal profiling of
the cellular proteome (Savitski et al., 2014). From this dataset,
we derived midpoints of unfolding T50 of 54.6 and 46.2◦C for
PAPSS1 and PAPSS2, respectively, and compared these to the T50
values of 45.8 and 39.8◦C for PAPSS1 and PAPSS2, measured
before (van den Boom et al., 2012), revealing a difference in
T50 of 8.3 and 5.8◦C for the two PAPS synthases. Even though
these numbers are from two studies using different methods, the
observed differences in T50 suggest that PAPS synthase protein
stability within cells may differ compared to previous in vitro
studies (van den Boom et al., 2012). Whether this is related to
intrinsic protein stability or protein interactions is a question
which remains to be answered.
HOLDING ON TO SOMETHING—HOW
LIGANDS, COFACTORS AND
SUBSTRATESAFFECTPROTEINSTABILITY
Functional proteins have not evolved to preserve a certain protein
fold, but rather to fulfill a certain biological function. Enzymes
have specific binding sites for strong and specific interactions
with their small-molecule substrates and products (Martínez
Cuesta et al., 2015). This specific binding relies on many
cooperatively acting interactions and may stabilize the protein,
making it more rigid. Indeed, many experiments studying
thermal or mechanical stability show strong stabilization
of proteins by binding their substrates or cofactors. This
includes, among others, adenylate kinases binding substrate
and inhibitory nucleotides (Mazal et al., 2018), PAPS synthases
binding their substrates or products ADP, APS, and PAPS
(van den Boom et al., 2012) as well as cohesins binding calcium
(Verdorfer and Gaub, 2018). But how do these newly formed
interactions contribute to the actual stability of the protein?
The Gibbs energy 1G is genuinely used to compare the
energetic differences between two states and in protein-ligand-
binding this refers to the bound and the unbound state of the
ligand. The Gibbs energy can further be split into contributions
of the enthalpy 1H describing the total energy of the system
observed and the temperature-dependent entropy 1S describing
the degrees of freedom or conformational states of similar energy.
The thermodynamic descriptions of protein-ligand binding focus
either on the ligand, especially in drug design (Claveria-Gimeno
et al., 2017), or how the energy landscape of protein folding and
stability is affected (Kabir et al., 2016; Hingorani et al., 2017). One
factor regarding ligand binding is the process of breaking existing
water networks in the unbound state in order for the ligand to
bind (Fox et al., 2017; Verteramo et al., 2019). Breakage and
reorganization of a strong water network displays an energetic
cost which ultimately reduces the affinity of drugs to their targets
(Fox et al., 2017). Thermodynamic analysis focusing mainly on
the binding effects on the protein itself include changes in protein
structure (Reyes et al., 2017) or stability (Kabir et al., 2016).
In some cases, binding of ligands may actually stabilize non-
native or intermediate conformations and therefore not always
leads to a stabilization of the protein target (Kabir et al., 2016).
However, stabilizing non-native interactions may be desirable in
drug design to reduce formation of, for example, toxic aggregates
(Vöpel et al., 2017; Perni et al., 2018).
PAPS synthases show consecutive binding and release of
sulfate, ATP, ADP, APS, and PAPS (Sekulic et al., 2007; Figure 2).
As all nucleotides involved are generated from ATP, it becomes
apparent that ATP availability fuels the cycle. Looking into crystal
structures and experimental data, ADP and APS appear to be
tightly bound to the protein (Harjes et al., 2005; Mueller and
Shafqat, 2013) and the structure of the protein is known to
be stabilized by these nucleotides (van den Boom et al., 2012).
The inhibitory or “dead-end” complex forms after the release
of the product PAPS, by re-binding of an APS nucleotide to
the ADP-kinase complex. This is a highly stabilized form of the
APS kinase (Sekulic et al., 2007; Mueller and Shafqat, 2013).
Considering thermal unfolding experiments in presence and
absence of APS described above (van den Boom et al., 2012),
one of the observed thermal unfolding transitions must be
caused by the formation of this inhibitory complex with APS
(Figure 1B). Due to the marked increase in stability by binding
ADP and especially APS, the formed complex may not only be
of inhibitory nature, but serves as a storage form in times of
ATP depletion.
Even though ATP is often thought to be a ubiquitously
available source of energy inside cells at up to two-digit
millimolar concentration, the levels of ATP are regulated by
different factors and may fluctuate significantly during the
lifetime of a cell (Beis and Newsholme, 1975; Ataullakhanov and
Vitvitsky, 2002; Bonora et al., 2012). However, in response to ATP
depletion resulting from stresses, kinases such as 5′-AMP protein
kinase become more active in order to rebalance the ATP/AMP-
ratio by phosphorylating substrates, regulating downstream gene
expression and ultimately the activity of ATP-generating systems
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(Hardie and Carling, 1997). DNA damage from irradiation and
oxidative stress caused by endogenous or environmental factors
are stresses that affect ATP levels temporarily (Budanov and
Karin, 2008). However, hyperosmotic shock (Dmitrieva et al.,
2011), resulting in an imperfect crowding adaptation (Gnutt
et al., 2017), as well as cellular starvation (Maddocks et al.,
2013) are known to cause DNA lesions as well. Further, as ATP
FIGURE 2 | The catalytic cycle of APS kinase. Schematic representation
including substrate binding and product release steps. An inhibitory or stable
storage complex is populated after PAPS release by binding of APS (lower left).
FIGURE 3 | Structural mapping of PAPSS2 point mutations. Known
disease-relevant mutations in PAPS synthase 2 isoform (red spheres) are
shown in a PAPS synthase structure (PDB: 1XNJ). The N-terminal APS kinase
is shown in gray, the C-terminal ATP-sulfurylase domain in black. Zoom,
disease relevant mutations in the APS kinase central beta-sheet (black). Amino
acid numbering reflects positions in PAPSS2. Table, solvent accessible
surface area (SASA) of sidechains derived from DSSP values. Values for amino
acids in the APS kinase domain have been derived from PDB structure 2AX4,
values for the ATP sulfurylase are from 1XNJ.
has been suggested to act as a hydrotrope helping to solubilize
proteins in the cellular environment, proteins may even become
prone to aggregation, if ATP is depleted for a longer period of
time (Patel et al., 2017). Considering changing ATP levels and
PAPS synthase stabilization via ligand binding, we propose that
the PAPSS2-ADP-APS complex within the APS kinase domain
represents a stable storage form not only of the enzyme, but also
for the APS nucleotide, of relevance in times in which ATP levels
are depleted.
INTRACELLULAR RECYCLING—
STABILITY AND DEGRADATION OF PAPS
SYNTHASES IN CELLS
Proteins within the cell are not only exposed to the
physicochemical forces described above, but also to enzymatic
post-translational modifications and some of these modifications
influence protein stability again. In Alzheimer’s disease, as an
example, the phosphorylated tau protein forms neurofibrillary
tangles and glycosylation defects have been observed in the
amyloid precursor protein (APP) and other proteins (Schedin-
Weiss et al., 2014). Ubiquitination is noteworthy here as it serves,
among other functions, to target proteins for active degradation
(Chaugule and Walden, 2016). A tetra-ubiquitin chain attached
to a lysine side chain of a target protein is sufficient for
recognition and degradation by the proteasome (Singh et al.,
2016). The attachment of ubiquitin is catalyzed by hundreds
of ubiquitin ligase-complexes (Chaugule and Walden, 2016).
Interestingly, this attachment depends on physicochemical
stability of the target protein as ubiquitination requires the
target peptide to be unfolded or intrinsically disordered (Prakash
et al., 2009); structured domains need to unfold partially before
ubiquitination can occur (Hagai et al., 2011) and conversely
ubiquitination destabilizes the protein fold (Hagai and Levy,
2010). Preliminary data for PAPS synthases indeed show
enhanced ubiquitination for PAPSS2 than for PAPSS1 upon
6 h treatment with the proteasome inhibitor MG-132 (data not
shown). Taken together, biophysical instability may translate
to biological instability involving active degradation by the
ubiquitin/proteasome machinery.
ONE PROTEIN, DIFFERENT MUTANTS AND
TWO MECHANISMS—UNDERSTANDING
PAPS SYNTHASE-RELATED DISEASES
AND APPLYING THIS KNOWLEDGE TO
DRUG DESIGN
Several neurodegenerative diseases present with aggregates
of certain proteins such as Aβ peptide in Alzheimer’s disease
(Masters et al., 2015), poly-Q repeats in Huntington’s disease
(McColgan and Tabrizi, 2018), and α-synuclein in Parkinson’s
disease (Poewe et al., 2017). Once disease progression was
linked to the cytotoxicity of the observed protein aggregates,
aggregation had been studied in detail and the actual toxic
oligomeric species identified (Knowles et al., 2014). Most
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recently, small molecules have been developed to alter
aggregation properties of the affected protein to treat the
according disease (Vöpel et al., 2017; Perni et al., 2018;
Limbocker et al., 2019).
While neurodegenerative diseases are well-studied, diseases
related to sulfation pathways remained underexplored with the
exception of heparin as an anti-coagulant (Tsai et al., 2017).
Furthermore, genetic defects in the gene for PAPS synthase 2
have been described with phenotypes of various forms of bone
and cartilage formation as well as androgen regulation and
polycystic ovary syndrome (Oostdijk et al., 2015). These PAPSS2
missense mutations include G78R (Kurima et al., 1998), T48R
(Noordam et al., 2009), C43Y, L76Q, V540D (Iida et al., 2013),
and G270D (Oostdijk et al., 2015). They are mapped on a
schematic representation of the PAPS synthase protein structure
(Figure 3), which shows that the APS kinase mutants are in close
spatial proximity.
Some of the mutations in PAPSS2 occurred homozygous such
as V540D (Iida et al., 2013; Oostdijk et al., 2015). However,
two studies describe clinical cases of compound heterozygous
mutations, where a missense mutation is observed in the genetic
background of a non-sense mutation (Noordam et al., 2009;
Oostdijk et al., 2015). Messenger RNAs of non-sense mutations
with their premature stop codon are substrates for non-sense-
mediated mRNA decay (Lloyd, 2018) and hence they are
regarded as null alleles. For three of the missense mutations,
G78R, T48R, and G270D, it is known that they are hypomorphic;
they are alleles with residual activity. For the G78R variant, very
little residual APS kinase activity was reported, but the ATP
sulfurylase activity remained similar to wild type (Kurima et al.,
1998), suggesting a folded and functioning ATP sulfurylase that
may act as a solubility anchor and prevent immediate aggregation
of the protein. For T48R and G270D, residual ability to support
SULT2A1-dependent DHEA sulfation was reported, however,
both mutated protein variants were also ubiquitinated and
degraded (Oostdijk et al., 2015), suggesting severely destabilized
protein folds.
These data suggest the existence of two different disease
mechanisms for the same PAPS synthase proteins. Residue
solvent accessibility extracted from DSSP values further
illustrates that G78R is more solvent exposed compared to the
buried amino acids (keeping in mind that glycine residues show
small solvent accessible surfaces in general due to the lack of a
side chain). For an understanding of PAPSS2-related pathologies,
it will be essential to investigate whether biophysical observation
can be correlated with disease progression.
Generally, once a protein’s molecular disease mechanisms is
classified as misfolding or aggregation, designing small molecule-
drugs is often the best way to recover that protein from its disease
states (Arosio et al., 2014; Vöpel et al., 2017; Chia et al., 2018).
This may be applicable to any other disease that compromises
the protein-folding homeostasis (Wood et al., 2018). However,
if the catalytic function of the protein is affected, this approach
appears not promising and cure is probably best to achieve by
supplementing patients with the lacking compounds that are no
longer synthesized by the affected protein. For defects in the
biosynthetic pathway of a cofactor, such supplementation can
involve a precursor of that cofactor (Edwards et al., 2015); for
PAPS synthase defects it may turn out to be a small subset of
sulfated biomolecules.
CONCLUSION AND OUTLOOK
Activated sulfate in form of PAPS is essential for driving
sulfation pathways inside cells. Even though a lack of PAPS
synthase activity results in severe disease states, biophysical
studies have only focused on measurements in buffered
solutions so far. These findings implicate that PAPS synthases
may be highly influenced by the cellular interior with
regard to ligand binding and protein ubiquitination and
degradation. At times, PAPS synthases form an inhibitory
complex with ADP and APS bound. This complex may be
reinterpreted as a storage form of the intrinsically instable
PAPSS2 protein and its substrate APS. In-cell studies are
required to determine the intracellular stability of PAPS
synthases. These findings shall provide further insight into
proposed molecular disease mechanisms and help to design
suitable drugs or treatment strategies of PAPS synthase-
related diseases.
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